BlockRx

BlockRx

Created using Figma
BlockRx is a series of initiatives by iSolve which leverage the Blockchain and iSolve’s Advanced Digital Ledger Technology™ (ADLT™). The platform is a comprehensive solution to fully integrate Life Science Researchers, BioPharma, Medical Device Manufactures, and Healthcare Providers to improve Patient Outcomes.
Sale
Oct 13, 2017
Jan 31, 2018
100% completed
Raised funds - no Data
past
  • 187 BKRX
    =
    1 ETH
    ( Oct 13, 2017 — Nov 2, 2017 )
  • 170 BKRX
    =
    1 ETH
    ( Nov 3, 2017 — Dec 2, 2017 )
  • 150 BKRX
    =
    1 ETH
    ( Dec 3, 2017 — Jan 2, 2018 )
  • 130 BKRX
    =
    1 ETH
    ( Jan 3, 2018 — Jan 31, 2018 )
Token Details
Ticker
BKRX
Accepted Currencies
ETH, BTC, LTC, FIAT
Company Details
Registered Country
United States
Additional Details
Platform
ERC20
Categories
Cryptocurrency, Health

About BlockRx

BlockRx is a series of initiatives by iSolve which leverage the Blockchain and iSolve’s Advanced Digital Ledger Technology™ (ADLT™). The platform is a comprehensive solution to fully integrate Life Science Researchers, BioPharma, Medical Device Manufactures, and Healthcare Providers to improve Patient Outcomes.

The goal for BlockRx is to interconnect systems that do not readily communicate with each other and create data provenance that satisfies regulatory and business requirements. By focusing on creating a network of Trusted Partners that are incentivized, BlockRx provides the solutions for facilitating the transfer of information.

Technical Info

ERC20

BlockRx Roadmap

  • 2014

  • Sponsorship by GPMS. Incorporation
  • 2015

  • Creation of the iSolce Platform Marketplace for Biotech IP. Partnership with Tech Transfer Office at University of South Dakota.
  • 2016

  • Creation of the BlockRx project. Partnerships. Development of ADLT.
  • 2017

  • Partnerships (Intel, YourEncore). BlockRx token offering. Pharma Co acquiring tokens. Live pharma use case. BlockRx token integration. Resource aquisition.
  • Read More
  • 2018

  • Pharma ecosystem initiation. BlockRx patient application. Resource acquisition. Product development. Expand sales and marketing

BlockRx Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Gordon Tampol
Cheif Executive Officer
unverified
Darryl G Glover
Chief Clinical Officer
unverified
Kasia Piskorska
Chief Financial Officer
unverified
Carlos Sanchez
Chief Technology Officer
unverified

BlockRx Last News

N/A
5.0 0
ICO Profile Vision Activity Potential Product Team

BlockRx Reviews

bitcoinexchangeguide.com
reviews

BlockRx aims to make the pharmaceutical industry more efficient through the use of blockchain technology. Thanks to BlockRx, pharmaceutical companies, patients, and other members of the drug supply chain can interact with one another in an immutable, decentralized environment. The blockchain and BlockRx technologies are being developed by iSolve, LLC.

The BlockRx token pre-sale is taking place throughout August, while the full sale will launch on September 21st at 11am EST. Stay tuned for more information and see how BlockRx wants to change the way pharmaceutical companies, patients, and healthcare providers interact.

Read More
  • Due to potential time differences in information updates, please verify the accuracy of each ICO project through its official website or other official communication channels.
  • This information is not intended as a recommendation or suggestion for ICO investment. Please conduct thorough research on the relevant information and make your own informed decision regarding ICO participation.
  • If you identify any issues or errors in this content, or if you wish to submit your own ICO project for listing, please contact us via email at info@icoholder.com.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.